ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / SGHT / news
TCMD (67) ANGO (36) SENS (40) DCTH (59) ⌘ Pro Terminal →

Why SGHT Stock slipped -1.82% Today — RQD Quant Desk Flash

$9.15 -1.82% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.10

Sight Sciences Inc. (SGHT) carries a Roarable Rating of D- (Sell) with 39/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $513.4M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on SGHT Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is SGHT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Sight Sciences Inc. (NASDAQ: SGHT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $9.15 (-1.82% 1D, market cap $513.4M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 9/20, FRED Macro Regime Fit 9/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, SGHT ranks #485 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does SGHT compare to TCMD and ANGO in the Health Care sector?
▼

Within the Health Care sector (Medical/Dental Instruments), SGHT carries a Roarable D- (39/100 RQD), trailing P/E of N/A, gross margin of 86.2%, and ROIC of -35.0%. By comparison, TCMD (Tactile Systems Technology Inc.) holds a C+ grade (67/100 RQD, P/E 28.9x, ROIC 17.1%, cap $521.9M) and ANGO (AngioDynamics Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -23.4%, cap $504.2M). Among the 5-stock peer group, TCMD leads on earnings multiple (28.9x) while TCMD leads on capital efficiency (17.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for SGHT?
▼

Per SGHT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001531177), Sight Sciences Inc. generated $77.4M in revenue (-3.1% YoY), -$38.4M in net income, and -$29.9M in free cash flow against $115.3M in total assets and $40.3M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $9.10 (-0.52%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (39/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.6% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • D-
025507510039
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D
Cash (3)Whales (15)SEC (9)Macro (9)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-8.5% Base Target
$10 Bull$8 Base$7 Bear
📬 FREE SGHT RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SGHT)Realized 20D OHLCV Swing Band: ±10.8%
Deterministic 5-Pillar Attribution (39/100 Composite)
🔍 WHY SGHT SCORES 39/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (38% of score)

20D Institutional Volume Accumulation (±10.8% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+9/20 pts (23% of score)

Altman Z-Score 2.16 (WATCH ZONE (1.8–3.0)) • Piotroski F-Score 5/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
31
Grade E$8.39+2.7% Next Q
Q2 (-2Q)
34
Grade E$8.62+4.8% Next Q
Q3 (-1Q)
36
Grade E$9.03+1.3% Next Q
Current
39
Grade D-$9.15-7.6% Hist 90D α
Trajectory: E (31) → D- (39)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a SGHT Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While SGHT currently carries a cautious 39/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Big institutional funds and options desks are actively positioning on the bullish side.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($8.63) and Max Pain ($9.61) forces dealer call-delta covering toward $10.20.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $SGHT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “SGHT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 39%NO 61%Trade / Inspect Odds →
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why SGHT Stock slipped -1.82% Today — RQD Quant Desk Flash

Sight Sciences Inc. (SGHT) slipped -1.82% to $9.15, trading at 91% of its 52-week range ($3.38 – $9.71). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.

  • ▸Technical Tape: Trading at 91% of its 52-week range ($3.38 – $9.71) with RSI-14 at 57.6 (BULLISH MOMENTUM).
  • ▸Volatility Profile: Historical 20-day realized swing band of ±10.8% around $9.15 (no active unusual options sweep snapshot on file).
  • ▸Fundamental Anchor: Roarable D- (Sell) backed by 86.2% gross margin and $0 annual free cash flow.
Live SGHT Headlines & Catalysts
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SGHT)

  • ✓Walkthrough of SGHT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
SGHT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +116.82%▲ ASCENDING CHANNEL
2026-11-03O $9.57H $9.57L $9.15C $9.15VOL 267.5K
RES: $10.48SUP: $4.80SMA50: $8.63SMA200: $6.01
$10.11$8.46$6.82$5.18$3.54RES $10.48SUP $4.80$9.152026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SGHT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SGHT Butterfly Map → + Track SGHT →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. -3.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on SGHT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SGHT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for SGHT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SGHT)

Health Care Rank #485 of 1015 ⚔️ TCMD vs SGHT Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SGHT vs. TCMD, ANGO, SENS, DCTH)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Sight Sciences Inc. (SGHT) ranks #485 by composite RQD confidence (39/100, grade D-) and #435 by equity capitalization ($513.4M). Within this direct 5-issuer industry benchmark cohort, TCMD leads on earnings valuation at 28.9x trailing P/E, while TCMD leads on capital efficiency and profitability with 17.1% ROIC and 75.9% gross margin. TCMD currently holds the highest overall quantitative score in the immediate peer group at 67/100 (C+) compared with SGHT at 39/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
SGHT ACTIVE
Sight Sciences Inc.
D- 39/100 — 86.2% -35.0% -1.82% $513.4M Benchmark Subject
TCMD
Tactile Systems Technology Inc.
C+ 67/100 28.9x 75.9% 17.1% -0.74% $521.9M /tcmd-vs-sght →
ANGO
AngioDynamics Inc.
D- 36/100 — 54.6% -23.4% -1.92% $504.2M /ango-vs-sght →
SENS
Senseonics Holdings Inc.
D- 40/100 — 44.7% -35.0% -5.57% $502.8M /sens-vs-sght →
DCTH
Delcath Systems Inc.
C- 59/100 — 86.2% 0.8% +1.78% $487.2M /dcth-vs-sght →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001531177 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Sight Sciences Inc. (SGHT) reported GAAP revenue of $77.4M (-3.1% vs. FY2024 revenue of $79.9M , and -4.6% cumulative change since FY2023) , GAAP net income of -$38.4M, operating cash flow of -$29.7M, and free cash flow of -$29.9M (-31.6% YoY). On the balance sheet, SGHT closed FY2025 with $115.3M in total assets against $40.3M in total debt (Altman Z-Score: 2.16, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $77.4M -$38.4M -$29.7M -$29.9M $115.3M $40.3M
FY2024 (FY) 2024-12-31 $79.9M -$51.5M -$22.4M -$22.7M $142.8M $39.4M
FY2023 (FY) 2023-12-31 $81.1M -$55.5M -$47.2M -$47.2M — —

3. SGHT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SGHT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Sight Sciences Inc. (NASDAQ: SGHT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 39/100 at a spot price of $9.15 (-1.82% 1D, market cap $513.4M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 9/20, FRED Macro Regime Fit 9/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, SGHT ranks #485 in composite RQD confidence.

How does SGHT compare to TCMD and ANGO in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), SGHT carries a Roarable D- (39/100 RQD), trailing P/E of N/A, gross margin of 86.2%, and ROIC of -35.0%. By comparison, TCMD (Tactile Systems Technology Inc.) holds a C+ grade (67/100 RQD, P/E 28.9x, ROIC 17.1%, cap $521.9M) and ANGO (AngioDynamics Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -23.4%, cap $504.2M). Among the 5-stock peer group, TCMD leads on earnings multiple (28.9x) while TCMD leads on capital efficiency (17.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for SGHT?

Per SGHT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001531177), Sight Sciences Inc. generated $77.4M in revenue (-3.1% YoY), -$38.4M in net income, and -$29.9M in free cash flow against $115.3M in total assets and $40.3M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is SGHT trading relative to its 50-day, 200-day, and 52-week technical levels?

SGHT last traded at $9.15 (-1.82% on volume of 227,074 shares), positioning the stock +6.03% above its 50-day simple moving average ($8.63) and +52.25% above its 200-day simple moving average ($6.01). Across its 52-week range of $3.38 to $9.71, SGHT sits at the 91.2% percentile with a 14-day RSI of 57.6 (BULLISH MOMENTUM) and an implied next-earnings move of ±10.8% ($8.16 to $10.14).

Direct Sub-Reports: SGHT RQD Cockpit SGHT 12M Forecast SGHT Earnings & Move SGHT Dividends & DRIP SGHT Insiders & 13F SGHT Whale Options SGHT Profit Sankey SGHT News & Why
ROARABLE RATING BRIEF • RQD 39/100 (D-) ✓ SEC XBRL & RQD VERIFIED

SGHT — Sight Sciences Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Sight Sciences Inc. (SGHT) earns a live Roarable RQD composite score of 39/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $9.15 (-1.82% 1D, market capitalization $513.4M).

  • Fundamental Cash Engine (3/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 86.2%, operating margin of -48.0%, and free cash flow yield of -5.67%.
  • Whale 13F & Options Flow (15/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (9/20) + Forensic Balance Sheet (9/20): Incorporates a 1.00x equity beta, Altman Z-Score of 2.16, Piotroski F-Score of 5/9, and Debt/Equity of 0.63x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Sight Sciences Inc. (SGHT) is a NASDAQ-listed issuer in the Health Care sector, within the Medical/Dental Instruments industry. The profile identifies the company's market capitalization as $0.5B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Sight Sciences Inc. (SGHT) reported $77.4M in annual revenue (up from $79.9M in FY2024, -3.1% YoY) and -$38.4M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($81.1M revenue, -$55.5M net income) through FY2025, SGHT scaled operating cash flow to -$29.7M and free cash flow to -$29.9M, backed by $115.3M in total assets against $40.3M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D- • RQD 39/100): Big institutional funds and options desks are actively positioning on the bullish side. Free cash flow yield of -5.67% and institutional whale pillar of 15/20. With Fundamental Cash Engine at 3/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $3.38 – $9.71 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -48.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

An investor should note that the only sector-level information available is the classification as Health Care / Medical/Dental Instruments, and the rating's macro regime pillar cites sector sensitivity without additional detail.

  • Key Question #1: Can SGHT sustain or expand its -48.0% operating margin and -35.0% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $77.4M and free cash flow of -$29.9M, how will capital allocation balance growth reinvestment against $40.3M in total debt?
  • Key Question #3: How sensitive is SGHT's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

SGHT Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Sight Sciences Inc. (SGHT) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to SGHT Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

SGHT Bull vs. Bear Conversation Board — What's Your Call at $9.15?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON SGHT 🐻 33% BEARISH CONVICTION
1. Pick Your Side on SGHT:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MA MacroHawk_NYC RQD DEBATE OPENER • Cross-Asset Macro Desk 🐂 BULLISH 🎯 Target: $10.90 (+17.0%)
📌 Pinned Debate

Institutional accumulation and options positioning score 15 of 20 in the RQD rating, and the stock trades near the top of its 52-week r

The street is overcomplicating Sight Sciences Inc. (SGHT). Institutional accumulation and options positioning score 15 of 20 in the RQD rating, and the stock trades near the top of its 52-week range at $9.57 against a range of $3.38 - $9.71.. With an RQD score of 39/100 (D-) and Forensic Balance Sheet at 9/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $10.07.

SectorRotator 🐂 BULL

@MacroHawk_NYC Agree on the RQD 39/100 quality, though with 1.0 beta I'm scaling in with half-size at $9.32 and keeping dry powder in case we test $8.67.

SK SkepticalCFA RQD DEBATE OPENER • Fundamental Contrarian 🐻 BEARISH 🎯 Target: $7.36 (-21.0%)
Spot @ $9.32

ROIC of -35%, FCF yield of -5.67%, and operating margin of -48% leave the fundamental cash engine scoring only 3 of 20 in the RQD ratin

Sitting on the sidelines or leaning short SGHT above $9.32. ROIC of -35%, FCF yield of -5.67%, and operating margin of -48% leave the fundamental cash engine scoring only 3 of 20 in the RQD rating.. Until Fundamental Cash Engine (3/20) and FCF yield (-5.67%) inflect higher, upside is capped near $9.71.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%